These pathways work through different brain circuits and metabolic processes
Clinical investigations and reviews have described changes in glucose-related biomarkers, lipid fractions, blood pressure measurements, and other cardiometabolic parameters when the peptide is evaluated in controlled settings
This hormone promotes insulin and suppresses glucagon
For background on how retatrutide works, see our mechanism of action guide
GLP-1 receptor agonists work by establishing steady-state concentrations in the body over time, and their glucose-lowering and appetite-suppressing effects develop progressively over several weeks
Primary Cellular Pathways GIP Receptor Activation Insulin Secretion and Lipid Metabolism GLP3 s most potent receptor interaction occurs at the glucose-dependent insulinotropic polypeptide (GIP) receptor, where it demonstrates enhanced activity compared to native GIP[4]